NCT03133637View on ClinicalTrials.gov

Ceftriaxone and Jaundice in Neonates

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Jaundice and Sepsis in Neonates
Interventions
DRUG

ceftriaxone

Eligible infants will receive ceftriaxone as standard of care for sepsis

Trial Locations (1)

14642

University of Rochester Medical Center, Rochester

All Listed Sponsors
lead

University of Rochester

OTHER

NCT03133637 - Ceftriaxone and Jaundice in Neonates | Biotech Hunter | Biotech Hunter